Steady State Phosphorus Mass Balance Model during Hemodialysis Based on a Pseudo One-Compartment Kinetic Model

Abstract

Purpose

Mathematical models of phosphorus kinetics and mass balance during hemodialysis are in early development. We describe a theoretical phosphorus steady state mass balance model during hemodialysis based on a novel pseudo one-compartment kinetic model.

Methods

The steady state mass balance model accounted for net intestinal absorption of phosphorus and phosphorus removal by both dialysis and residual kidney function. Analytical mathematical solutions were derived to describe time-dependent intradialytic and interdialytic serum phosphorus concentrations assuming hemodialysis treatments were performed symmetrically throughout a week.

Results

Results from the steady state phosphorus mass balance model are described for thrice weekly hemodialysis treatment prescriptions only. The analysis predicts 1) a minimal impact of dialyzer phosphorus clearance on predialysis serum phosphorus concentration using modern, conventional hemodialysis technology, 2) variability in the postdialysis-to-predialysis phosphorus concentration ratio due to differences in patient-specific phosphorus mobilization, and 3) the importance of treatment time in determining the predialysis serum phosphorus concentration.

Conclusions

We conclude that a steady state phosphorus mass balance model can be developed based on a pseudo one-compartment kinetic model and that predictions from this model are consistent with previous clinical observations. The predictions from this mass balance model are theoretical and hypothesis-generating only; additional prospective clinical studies will be required for model confirmation.

Keywords

Clearance Dietary intake Hemodialysis Mass balance Mathematical model Phosphorus

References

Block

G.A.

, Hulbert-Shearon

T.E.

, Levin

N.W.

, Port

F.K.

. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998; 31(4): 607–617.

Covic

, Kothawala

, Bernal

, Robbins

, Chalian

, Goldsmith

. Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease. Nephrol Dial Transplant. 2009; 24(5): 1506–1523.

Floege

, Kim

, Ireland

ARO Investigators. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population.

Nephrol Dial Transplant. 2011; 26(6): 1948–1955.

Naves-Díaz

, Passlick-Deetjen

, Guinsburg

Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study.

Nephrol Dial Transplant. 2011; 26(6): 1938–1947.

Palmer

S.C.

, Hayen

, Macaskill

Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis.

JAMA. 2011; 305(11): 1119–1127.

Rufino

, de Bonis

, Martín

Is it possible to control hyperphosphataemia with diet, without inducing protein malnutrition?

Nephrol Dial Transplant. 1998; 13(Suppl 3): 65–67.

Moe

S.M.

, Zidehsarai

M.P.

, Chambers

M.A.

Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease.

Clin J Am Soc Nephrol. 2011; 6(2): 257–264.

Sherman

R.A.

, Mehta

. Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. Clin J Am Soc Nephrol. 2009; 4(8): 1370–1373.

Sherman

R.A.

, Mehta

. Dietary phosphorus restriction in dialysis patients: potential impact of processed meat, poultry, and fish products as protein sources. Am J Kidney Dis. 2009; 54(1): 18–23.

10.

Tonelli

, Pannu

, Manns

. Oral phosphate binders in patients with kidney failure. N Engl J Med. 2010; 362(14): 1312–1324.

11.

Agar

B.U.

, Akonur

, Cheung

A.K.

, Leypoldt

J.K.

. A simple method to estimate phosphorus mobilization in hemodialysis using only predialytic and postdialytic blood samples. Hemodial Int. 2011; 15(Suppl 1): S9–S14.

12.

Agar

B.U.

, Akonur

, Lo

Y.C.

, Cheung

A.K.

, Leypoldt

J.K.

. Kinetic model of phosphorus mobilization during and after short and conventional hemodialysis. Clin J Am Soc Nephrol. 2011; 6(12): 2854–2860.

13.

Gotch

F.A.

, Panlilio

, Sergeyeva

A kinetic model of inorganic phosphorus mass balance in hemodialysis therapy.

Blood Purif. 2003; 21(1): 51–57.

14.

Eloot

, Torremans

, De Smet

Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds.

Kidney Int. 2005; 67(4): 1566–1575.

15.

Basile

, Libutti

, Di Turo

A.L.

Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis.

Nephrol Dial Transplant. 2011; 26(4): 1296–1303.

16.

Kerr

P.G.

, Lo

, Chin

, Atkins

R.C.

. Dialyzer performance in the clinic: comparison of six low-flux membranes. Artif Organs. 1999; 23(9): 817–821.

17.

Katopodis

K.P.

, Chala

, Koliousi

Role of the dialyzer membrane on the overall phosphate kinetics during hemodialysis.

Blood Purif. 2005; 23(5): 359–364.

18.

Tonelli

, Wang

, Hemmelgarn

, Lloyd

, Manns

; Alberta Kidney Disease Network. Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients. Am J Kidney Dis. 2009; 54(6): 1108–1115.

19.

Penne

E.L.

, van der Weerd

N.C.

, van den Dorpel

M.A.

CONTRAST Investigators. Short-term effects of online hemodiafiltration on phosphate control: a result from the randomized controlled Convective Transport Study (CONTRAST).

Am J Kidney Dis. 2010; 55(1): 77–87.

20.

Sugisaki

, Onohara

, Kunitomo

. Dynamic behavior of plasma phosphate in chronic dialysis patients. Trans Am Soc Artif Intern Organs. 1982; 28: 302–307.

21.

Spalding

E.M.

, Chamney

P.W.

, Farrington

. Phosphate kinetics during hemodialysis: Evidence for biphasic regulation. Kidney Int. 2002; 61(2): 655–667.

22.

Agar

B.U.

, Troidle

, Finkelstein

F.O.

, Kohn

O.F.

, Akonur

, Leypoldt

J.K.

. Patient-specific phosphorus mobilization clearance during nocturnal and short daily hemodialysis. Hemodial Int.

23.

Agar

B.U.

, Leypoldt

, Akonur

, Hutchcraft

, Culleton

B.F.

. Determinants of phosphorus kinetic parameters during haemodialysis: Results from the HEMO Study. (Abstract). Nephrol Dial Transplant. 2012; 27(Suppl 2): ii49.

24.

Mucsi

, Hercz

, Uldall

, Ouwendyk

, Francoeur

, Pierratos

. Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int. 1998; 53(5): 1399–1404.

25.

Ayus

J.C.

, Mizani

M.R.

, Achinger

S.G.

, Thadhani

, Go

A.S.

, Lee

. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol. 2005; 16(9): 2778–2788.

26.

Ayus

J.C.

, Achinger

S.G.

, Mizani

M.R.

Phosphorus balance and mineral metabolism with 3 h daily hemodialysis.

Kidney Int. 2007; 71(4): 336–342.

27.

Troidle

, Hotchkiss

, Finkelstein

. A thrice weekly incenter nocturnal hemodialysis program. Adv Chronic Kidney Dis. 2007; 14(3): 244–248.

28.

Bugeja

, Dacouris

, Thomas

In-center nocturnal hemodialysis: another option in the management of chronic kidney disease.

Clin J Am Soc Nephrol. 2009; 4(4): 778–783.

29.

Vaithilingam

, Polkinghorne

K.R.

, Atkins

R.C.

, Kerr

P.G.

. Time and exercise improve phosphate removal in hemodialysis patients. Am J Kidney Dis. 2004; 43(1): 85–89.

30.

Penne

E.L.

, van der Weerd

N.C.

, Grooteman

M.P.

CONTRAST investigators. Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients.

Clin J Am Soc Nephrol. 2011; 6(2): 281–289.

31.

Sigrist

M.K.

, Devlin

, Taal

M.W.

, Fluck

R.J.

, McIntyre

C.W.

. Length of interdialytic interval influences serum calcium and phosphorus concentrations. Nephrol Dial Transplant. 2005; 20(8): 1643–1646.

32.

Daugirdas

J.T.

, Chertow

G.M.

, Larive

Frequent Hemodialysis Network (FHN) Trial Group. Effects of frequent hemodialysis on measures of CKD mineral and bone disorder.

J Am Soc Nephrol. 2012; 23(4): 727–738.

33.

Tentori

, Blayney

M.J.

, Albert

J.M.

Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Am J Kidney Dis. 2008; 52(3): 519–530.

34.

Gotch

F.A.

, Panlilio

, Sergeyeva

Effective diffusion volume flow rates (Qe) for urea, creatinine, and inorganic phosphorous (Qeu, Qecr, QeiP) during hemodialysis.

Semin Dial. 2003; 16(6): 474–476.

35.

Bhimani

J.P.

, Ouseph

, Ward

R.A.

. Effect of increasing dialysate flow rate on diffusive mass transfer of urea, phosphate and beta2–microglobulin during clinical haemodialysis. Nephrol Dial Transplant. 2010; 25(12): 3990–3995.

36.

Sargent

J.A.

, Gotch

F.A.

. Mathematic modeling of dialysis therapy. Kidney Int. 1980; 18(Suppl 10): S2–S10.

37.

Sargent

J.A.

, Gotch

F.A.

. Principles and biophysics of dialysis. In: Jacobs

, Kjellstrand

C.M.

, Koch

K.M.

, Winchester

J.F.

, eds. Replacement of Renal Function by Dialysis, 4th edition. Dordrecht: Kluwer Academic; 1996: 34–102.

38.

DeSoi

C.A.

, Umans

J.G.

. Phosphate kinetics during high-flux hemodialysis. J Am Soc Nephrol. 1993; 4(5): 1214–1218.